Stevens-Johnson syndrome after ChAdOx1 nCoV-19 vaccine
Indian J Dermatol Venereol Leprol
.
2022 Sep-Oct;88(5):702.
doi: 10.25259/IJDVL_941_2021.
Authors
Pedro Alves da Cruz Gouveia
1
,
Larissa N F Cavalcanti
2
,
Lucas C F Alves
3
,
Daniel M Almeida
1
,
Lucília Willa A Barretto
2
Affiliations
1
Department of Internal Medicine, Oswaldo Cruz University Hospital, Pernambuco, Brazil.
2
Department of Dermatology, Oswaldo Cruz University Hospital, Pernambuco, Brazil.
3
Department of Infectious Diseases, Oswaldo Cruz University Hospital, Pernambuco, Brazil.
PMID:
35986626
DOI:
10.25259/IJDVL_941_2021
No abstract available
Publication types
Letter
Comment
MeSH terms
ChAdOx1 nCoV-19*
Humans
Stevens-Johnson Syndrome* / diagnosis
Stevens-Johnson Syndrome* / etiology
Vaccination
Substances
ChAdOx1 nCoV-19